Brigit Biofarmaka Teknologi Tbk. vs Panca Global Kapital Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Panca Global Kapital Tbk. trades at Rp93 (market cap 334.2B, 33.83M 24h volume). The key difference: Panca Global Kapital Tbk. is the larger of the two by market cap, and Panca Global Kapital Tbk. is more actively traded (33.83M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | PEGE | |
|---|---|---|
Market Cap | 172.82B | 334.2B |
Volume | 592.2K | 33.83M |
Lot | 5.92K | 338.26K |
Turnover | 147.05M | 3.12B |
Average Price | 248.31 | 92.19 |
Value | 147.05M | 3.12B |
Indicative Equilibrium Price | 254 | 93 |
Indicative Equilibrium Volume | 10 | 4.55K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Panca Global Securities Tbk. (the Company) was established based on notarial deed No. 20 dated August 13th, 1999 of Fathiah Helmi, S.H., notary in Jakarta. The company's articles of association has been amended several times, and the latest amended on August 30, 2004 concerning company's plan for public offering. The company divides business into 2 divisions, stock brokerage and investment management division.
Read more on PEGE →